Eyelid Tumor
6
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma
Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures
The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.
Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery